Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Oncology Reports|January 5, 2006
Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemiaGeertruy Te Kronnie, Silvio Bicciato, Lisa Franceschini, et al.
Advances in Biological Regulation|September 23, 2021
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cellsSalihanur Darici, Manuela Zavatti, Luca Braglia, et al.
Blood|May 26, 2012
Sox4 cooperates with CREB in myeloid transformationSalemiz Sandoval, Christina Kraus, Er-Chieh Cho, et al.
Blood|November 5, 2017
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemiaValentina Serafin, Giorgia Capuzzo, Gloria Milani, et al.
Blood|November 5, 2010
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockersSerena Pillozzi, Marika Masselli, Emanuele De Lorenzo, et al.
Oncotarget|July 19, 2016
Annexin 2A sustains glioblastoma cell dissemination and proliferationFrancesca Maule, Silvia Bresolin, Elena Rampazzo, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 21, 2014
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interactionMarianeve Carotenuto, Pasqualino de Antonellis, Cristina Maria Chiarolla, et al.
Pageof 4